Hypercoagulation Analyzer
Order Name
HYPRCOAGAN
Test Number: 1506500
Revision Date 02/27/2023
Test Number: 1506500
Revision Date 02/27/2023
| Test Name | Methodology | LOINC Code |
|---|---|---|
|
Hypercoagulation Analyzer
|
| SPECIMEN REQUIREMENTS | ||||
|---|---|---|---|---|
| Specimen | Specimen Volume (min) | Specimen Type | Specimen Container | Transport Environment |
| Preferred | See Instructions | See Instructions | See Special Instructions | See Instructions |
| Instructions | Due to the national shortage of 3.2% sodium citrate blue top tubes - Note change in tubes to collect. Please list the patient's anticoagulant on the "Coagulopathy Questionnaire Form" and submit with specimen or fax to 918-744-3236. Please Collect the following tubes: Seven (2.7mL) 3.2% Sodium Citrate (Blue Top) tubes, (Double Spin and Freeze Aliquots if not tested w/in 4 hours) Two (4.7mL) EDTA (Lavender Top) tubes, (Keep Whole Blood) One (10mL) Clot Activator SST (Red/Gray Top) tube. Each 2.7mL Sodium Citrate 3.2% (Blue Top) tube must be filled to the proper level, no hemolysis. Improperly filled tubes can give erroneous results. Whole blood must be transported to lab immediately. If testing cannot be started within 4 hours of collection the specimen must be double spun then 1.5mL plasma aliquot from each tube into individual plastic aliquot tubes and freeze. Do not pool aliquots together! A fasting specimen is preferred but Not required. Coagulopathy Questionnaire Form Double Spin Procedure |
|||
| GENERAL INFORMATION | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Testing Schedule | Mon - Fri | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Expected TAT | Testing dependent | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Clinical Use | A comprehensive algorithm used to assess the cause of hypercoagulability. Not recommended when patients are taking Pradaxa®, Xarelto® and Apixaban® See More Information. Algorithm begins with an Activated Protein C Resistance, Lupus sensitive PTT, Prothrombin time (PT), Prothrombin Gene Mutation, and a Partical Thromboplastin Time (PTT). Further testing is generated based on the results of these tests. A pathology interpretation is included with all orders. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CPT Code(s) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Lab Section | Coagulation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||